Adaptimmune Therapeutics PLC (ADAP)
0.6048
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.5958
-0.01
(-1.49%)
After-Hours: 20:00
Adaptimmune Therapeutics Total Liabilities (Quarterly): 237.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 6.628M |
| NuCana PLC | 20.32M |
| TC BioPharm (Holdings) PLC | 6.156M |
| Verona Pharma PLC | 251.33M |
| Autolus Therapeutics PLC | 350.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 317.44M |
| Shareholders Equity (Quarterly) | 79.99M |
| Debt to Equity Ratio | 0.6234 |
| Current Ratio | 3.848 |
| Net Debt Paydown Yield | -4.10% |